Journal article
Diagnostic value of intereye difference metrics for optic neuritis in aquaporin-4 antibody seropositive neuromyelitis optica spectrum disorders
- Abstract:
- Optic neuritis (ON), a central manifestation of multiple inflammatory central nervous system (CNS) disorders, has seen remarkable advances in diagnostic and therapeutic strategies due to rapid progress in imaging technologies. This review systematically summarizes recent high-quality literature focusing on the latest progress of optical coherence tomography (OCT), optical coherence tomography angiography (OCTA), magnetic resonance imaging (MRI), and diffusion tensor imaging (DTI) in ON. It further explores the integrative application and clinical value of multimodal imaging combined with immune biomarkers. Additionally, the application of artificial intelligence (AI) and deep learning (DL) in image analysis is discussed. This review highlights current innovations and proposes future directions for establishing multicenter standardized protocols, facilitating precision diagnostics, and promoting personalized management, thereby accelerating clinical translation and advancing neuroimmunological ophthalmology
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Version of record, pdf, 2.4MB, Terms of use)
-
- Publisher copy:
- 10.1136/jnnp-2022-330608
Authors
+ Guthy Jackson Charitable Foundation
More from this funder
- Funder identifier:
- 10.13039/100008087
- Grant:
- NA
- Publisher:
- BMJ Publishing Group
- Journal:
- Journal of Neurology, Neurosurgery and Psychiatry More from this journal
- Volume:
- 94
- Issue:
- 7
- Pages:
- 560-566
- Publication date:
- 2023-02-21
- DOI:
- EISSN:
-
1468-330X
- ISSN:
-
0022-3050
- Language:
-
English
- Keywords:
- Pubs id:
-
1313538
- Local pid:
-
pubs:1313538
- Source identifiers:
-
W4321442890
- Deposit date:
-
2026-04-30
- ARK identifier:
This ORA record was generated from metadata provided by an external service. It has not been edited by the ORA Team.
Terms of use
- Copyright date:
- 2023
If you are the owner of this record, you can report an update to it here: Report update to this record